adenosine has been researched along with Sepsis in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.22) | 18.7374 |
1990's | 5 (11.11) | 18.2507 |
2000's | 11 (24.44) | 29.6817 |
2010's | 20 (44.44) | 24.3611 |
2020's | 8 (17.78) | 2.80 |
Authors | Studies |
---|---|
Alves-Filho, JC; Borges, MC; Caetité, D; Castro, ÍMS; Cunha, FQ; Cunha, TM; Damaceno, MA; Donate, PB; Ferreira, RG; Fonseca, DM; Kauffenstein, G; Linden, J; Melo, PH; Menezes-Silva, L; Nakaya, HI; Nascimento, DC; Oliveira, AER; Paschoal, JAR; Peres, RS; Piñeros, AR; Quesniaux, V; Ryffel, B; Toller-Kawahisa, JE; Veras, FP; Viacava, PR; Zamboni, DS; Zoppi, D | 1 |
Chen, C; Chen, Y; Jiao, Y; Tang, D; Wu, Y; Xu, S; Yu, W; Zhu, L | 1 |
Ma, T; Yu-Jing, L; Zhang, T | 1 |
Chen, G; Fu, J; Ma, T; Zhang, T; Zhao, J | 1 |
Azambuja, JH; Begnini, K; Bertoni, APS; Braganhol, E; da Cruz, LLP; da Silveira, F; de Souza, PO; Gelsleichter, NE; Haas, CB; Hasko, G; Leite, RO; Mohr, KR; Prá, MD; Soares, MS; Spanevello, RM; Wink, MR | 1 |
Cata, JP; Guo, K; Miao, C; Ortoga, L; Qu, M; Shao, Y; Shi, Y; Spencer, CB; Wang, Y; Wang, Z; Wu, D; Zhang, H | 1 |
Bai, J; Bao, X; Li, Z; Liu, N; Liu, X; Lv, D; Ren, H; Sun, H; Tang, L; Zhang, Q; Zhou, X; Zhuang, S | 1 |
Cekic, C | 1 |
Cao, Y; Fu, C; Guo, W; Tang, S; Xu, Q | 1 |
Dubois, LG; Gilchrist, JJ; Ginsburg, GS; Hill, AV; Jaslow, SL; Ko, DC; Ko, ER; Langley, RJ; Moseley, MA; Mturi, N; Mwarumba, S; Njuguna, P; Pirinen, M; Pittman, KJ; Rautanen, A; Rouse, DC; Salinas, RE; Scott, JA; Thompson, JW; Tsalik, EL; Wang, L; Williams, TN; Woods, CW | 1 |
Bai, ZY; Feng, WS; Li, K; Yang, YY; Zeng, MN; Zheng, XK; Zhou, N | 1 |
Hsueh, PR; Hsueh, SC; Hwang, JJ; Jean, SS | 1 |
Braun, OÖ; Gustafsson, D; Rahman, M; Thorlacius, H; Wang, Y | 1 |
Bauzá, G; Moitra, R; Remick, D | 1 |
Åsenblad, N; Becker, RC; Cannon, CP; Held, C; Husted, SE; James, SK; Siegbahn, A; Steg, PG; Storey, RF; Varenhorst, C; Wallentin, L; Ycas, J | 1 |
Dobson, GP; Griffin, MJ; Letson, HL | 2 |
Masereeuw, R; Peters, E; Pickkers, P | 1 |
Serebruany, VL | 1 |
Coenen, MJ; Diamantea, F; Giamarellos-Bourboulis, EJ; Groothuismink, JM; Kox, M; Pickkers, P; Prekates, A; Ramakers, BP; Riksen, NP; Routsi, C; Savva, A; Sinapidis, D; Smits, P; Tasioudis, C; Toutouzas, K; van der Hoeven, JG; Vermeulen, SH | 1 |
Bao, R; Deng, X; Hou, J; Li, J; Shui, X; Yang, T; Zhu, X | 1 |
Kaufmann, I; Kreth, S; Ledderose, C; Luchting, B; Thiel, M | 1 |
Bodnár, Z; Boissonneault, GA; Hajdu, Z; Keresztes, T; Kovács, I; Sipka, S | 1 |
Pickkers, P; Ramakers, BP | 1 |
Belikoff, B; Hatfield, S; Remick, DG; Sitkovsky, M | 1 |
Cao, H; Cen, Y; Jiang, W; Li, B; Li, J; Liu, X; Pan, X; Zheng, J; Zheng, X; Zhou, H | 1 |
Pickkers, P; Ramakers, BP; Riksen, NP; Smits, P; van der Hoeven, JG | 1 |
Chandra, R; Csóka, B; Deitch, EA; Gergely, P; Haskó, G; Koscsó, B; Németh, ZH; Pacher, P; Rolandelli, RH; Spolarics, Z; Thompson, LF; Virág, L | 1 |
Bernstein, SH; Deaglio, S; Longhi, MS; Robson, SC; Serra, S | 1 |
Caldwell, CC; Sitkovsky, MV; Thiel, M | 1 |
Dierkes, S; Hennersdorf, MG; Perings, C; Strauer, BE | 1 |
Fang, G; Linden, J; Scheld, WM; Sullivan, GW | 1 |
Byk, G; Chaimovitz, C; Czeiger, D; Douvdevani, A; Mazar, J; Mukmenev, I; Rogachev, B; Shaked, G; Ziv, NY; Zlotnik, M | 1 |
Conlon, BA; Law, WR; Ross, JD | 2 |
Bennett, T; Gardiner, SM; Jolly, L; Kemp, PA; March, JE | 1 |
Mollitt, DL; Todd, JC | 1 |
Ferguson, JL; Law, WR; Miller, RN; Motew, SJ; Mourelatos, MG | 1 |
Thijs, A; Thijs, LG | 1 |
Alden, KJ; Ferguson, JL; Law, WR; Motew, SJ; Mourelatos, MG; Sam, AD; Sharma, AC | 1 |
Unkle, DW | 1 |
Ferguson, JL; Law, WR; Rice, AN; Sam, AD; Sharma, AC | 2 |
Cloutier, RL | 1 |
Craddock, PR; Gilberstadt, S; Jacob, HS; Silvis, S; VanSanten, L; Yawata, Y | 1 |
10 review(s) available for adenosine and Sepsis
Article | Year |
---|---|
The immunomodulatory function of adenosine in sepsis.
Topics: Adenosine; Animals; Immunity; Immunomodulation; Inflammation; Sepsis | 2022 |
Modulation of myeloid cells by adenosine signaling.
Topics: Adenosine; Animals; Autoimmune Diseases; Dendritic Cells; Humans; Infections; Myeloid Cells; Neoplasms; Receptors, Purinergic P1; Sepsis; Signal Transduction | 2020 |
The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury.
Topics: Acute Kidney Injury; Adenosine; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Cattle; Clinical Trials, Phase II as Topic; Critical Illness; Drug Evaluation, Preclinical; Endotoxemia; Forecasting; Humans; Intestines; Multicenter Studies as Topic; Receptors, Purinergic P1; Recombinant Fusion Proteins; Sepsis | 2014 |
Modulation of innate immunity by adenosine receptor stimulation.
Topics: Adenosine; Animals; Humans; Immunity, Innate; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Receptors, Purinergic P1; Sepsis | 2011 |
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.
Topics: Adenosine; Animals; Autoimmune Diseases; Humans; Hydrolases; Inflammation; Neoplasms; Reperfusion Injury; Respiratory Tract Diseases; Sepsis | 2013 |
The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases.
Topics: Adenosine; Animals; Communicable Diseases; Humans; Immunity, Innate; Inflammation; Receptor, Adenosine A2A; Receptors, Purinergic P1; Sepsis | 2003 |
Advances in understanding adenosine as a plurisystem modulator in sepsis and the systemic inflammatory response syndrome (SIRS).
Topics: Adenosine; Animals; Cytokines; Humans; Immune System; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Sepsis; Systemic Inflammatory Response Syndrome | 2005 |
The extracellular cardiac purine metabolome in sepsis.
Topics: Adenosine; Adenosine Deaminase; Allosteric Regulation; Animals; Humans; Macrophages, Peritoneal; Myocardium; Purines; Receptors, Purinergic P1; RNA, Messenger; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2007 |
Pathogenesis of renal failure in sepsis.
Topics: Acute Kidney Injury; Adenosine; Endothelin-1; Humans; Interleukins; Leukotrienes; Nitric Oxide; Platelet Activating Factor; Renal Circulation; Sepsis; Tumor Necrosis Factor-alpha | 1998 |
When sepsis is only an appearance.
Topics: Adenosine; Dehydration; Diagnosis, Differential; Electrocardiography; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Hypoglycemia; Nervous System Diseases; Sepsis; Wolff-Parkinson-White Syndrome | 2001 |
2 trial(s) available for adenosine and Sepsis
Article | Year |
---|---|
Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis.
Topics: Adenosine; Adolescent; Biomarkers; Female; Genome-Wide Association Study; Human Genetics; Humans; Machine Learning; Male; Models, Biological; Polymorphism, Single Nucleotide; Salmonella; Salmonella Infections; Sepsis | 2017 |
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study.
Topics: Adenosine; Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pneumonia; Sepsis; Ticagrelor; Ticlopidine; Treatment Outcome | 2014 |
33 other study(ies) available for adenosine and Sepsis
Article | Year |
---|---|
Sepsis expands a CD39
Topics: Adenosine; Animals; Antigens, CD; Apyrase; Cellular Reprogramming; Immune Tolerance; Macrophages; Mice; Plasma Cells; Receptor, Adenosine A2A; Sepsis | 2021 |
METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome.
Topics: Acute Lung Injury; Adenosine; Humans; Intracellular Signaling Peptides and Proteins; Methyltransferases; Respiratory Distress Syndrome; RNA, Messenger; Sepsis; Tripartite Motif Proteins | 2022 |
Improvement of the sepsis survival rate by adenosine 2a receptor antagonists depends on immune regulatory functions of regulatory T-cells.
Topics: Adenosine; Animals; CTLA-4 Antigen; Forkhead Transcription Factors; Mice; Purinergic P1 Receptor Antagonists; Sepsis; Survival Rate; T-Lymphocytes, Regulatory | 2022 |
ATPergic signaling disruption in human sepsis as a potential source of biomarkers for clinical use.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Apyrase; Biomarkers; Humans; Sepsis; Shock, Septic | 2023 |
METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury.
Topics: Acute Lung Injury; Adenosine; Animals; Ferroptosis; Mice; Sepsis; Up-Regulation | 2023 |
Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis.
Topics: Adenosine; Animals; Anti-Inflammatory Agents; Bacterial Load; Cytokines; Enhancer of Zeste Homolog 2 Protein; Humans; Immunity, Innate; Jumonji Domain-Containing Histone Demethylases; Lung; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; Phagocytosis; Sepsis | 2019 |
Ticagrelor alleviates sepsis-induced myocardial injury via an adenosine-dependent pathway in a mouse sepsis model.
Topics: Adenosine; Animals; Apoptosis; Disease Models, Animal; Mice; Sepsis; Ticagrelor | 2020 |
An integrated metabolomic strategy for the characterization of the effects of Chinese yam and its three active components on septic cardiomyopathy.
Topics: Adenosine; Allantoin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arbutin; Biomarkers; Cardiomyopathies; Cardiotonic Agents; China; Dietary Supplements; Dioscorea; Disease Models, Animal; Energy Metabolism; Female; Immunologic Factors; Male; Metabolomics; Plant Extracts; Plant Tubers; Principal Component Analysis; Random Allocation; Rats, Wistar; Sepsis | 2018 |
Ticagrelor: A promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci.
Topics: Adenosine; Animals; Anti-Bacterial Agents; Blood Platelets; Drug Resistance, Multiple, Bacterial; Gram-Positive Cocci; Humans; Multiple Organ Failure; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Sepsis; Ticagrelor | 2019 |
Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis.
Topics: Adenosine; Animals; Blood Platelets; Chemokines, CXC; Disease Models, Animal; Lung Injury; Macrophage-1 Antigen; Male; Mice; Neutrophil Infiltration; Neutrophils; Platelet Aggregation; Pulmonary Edema; Purinergic P2Y Receptor Antagonists; Sepsis; Ticagrelor | 2014 |
Adenosine receptor antagonists effect on plasma-enhanced killing.
Topics: Adenosine; Animals; Blood Bactericidal Activity; Cells, Cultured; Colon; Colony Count, Microbial; Female; Macrophages, Peritoneal; Mice; Mice, Inbred ICR; Peritoneal Lavage; Phagocytosis; Plasma; Purinergic P1 Receptor Antagonists; Sepsis; Serum Bactericidal Test | 2014 |
Adenosine, lidocaine and Mg2+ (ALM) induces a reversible hypotensive state, reduces lung edema and prevents coagulopathy in the rat model of polymicrobial sepsis.
Topics: Adenosine; Animals; Blood Coagulation Disorders; Disease Models, Animal; Drug Therapy, Combination; Edema; Hypotension; Infusions, Intravenous; Lidocaine; Lung Diseases; Magnesium; Male; Partial Thromboplastin Time; Prothrombin Time; Rats; Rats, Sprague-Dawley; Sepsis | 2014 |
Ticagrelor shift from PLATO to PEGASUS: Vanished mortality benefit, excess cancer deaths, massive discontinuations, and overshooting target events.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clopidogrel; Follow-Up Studies; Hemorrhage; Humans; Mortality; Neoplasms; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Sepsis; Ticagrelor; Ticlopidine | 2015 |
Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction, and Mortality in Sepsis Patients.
Topics: Adenosine; Aged; AMP Deaminase; Community-Acquired Infections; Critical Care; Cytokines; Female; Genotype; Humans; Immune System; Immunity, Innate; Immunosuppression Therapy; Infections; Inflammation; Male; Middle Aged; Monocytes; Multiple Organ Failure; Pneumonia; Pneumonia, Ventilator-Associated; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prospective Studies; Sepsis | 2015 |
Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Topics: 5'-Nucleotidase; Adenosine; Adenosine A2 Receptor Agonists; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Blotting, Western; Cells, Cultured; Culture Media, Conditioned; Cyclic AMP Response Element-Binding Protein; E2F1 Transcription Factor; Mice, Inbred BALB C; Phenethylamines; Receptor, Adenosine A2A; RNA Interference; Sepsis; T-Lymphocytes, Regulatory; Up-Regulation | 2016 |
Small-Volume Adenosine, Lidocaine, and Mg2+ 4-Hour Infusion Leads to 88% Survival after 6 Days of Experimental Sepsis in the Rat without Antibiotics.
Topics: Acidosis; Adenosine; Animals; Anti-Bacterial Agents; C-Reactive Protein; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Edema; Hyperkalemia; Infusions, Intravenous; Interleukin-1beta; Interleukin-6; Lidocaine; Magnesium Sulfate; Male; Rats; Sepsis | 2016 |
Reduced ligand affinity leads to an impaired function of the adenosine A2A receptor of human granulocytes in sepsis.
Topics: Adenosine; Adenylyl Cyclases; Cells, Cultured; Cytokines; Humans; Lipopolysaccharides; Neutrophils; Protein Isoforms; Reactive Oxygen Species; Receptor, Adenosine A2A; Sepsis | 2009 |
Increased serum adenosine and interleukin 10 levels as new laboratory markers of increased intra-abdominal pressure.
Topics: Abdomen; Adenosine; Adult; Aged; Biomarkers; Cohort Studies; Compartment Syndromes; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intensive Care Units; Interleukin-10; Intestinal Obstruction; Male; Middle Aged; Pancreatitis; Peritonitis; Pressure; Prognosis; Risk Assessment; Sensitivity and Specificity; Sepsis | 2010 |
Adenosine-mediated attenuation of the innate immune response for only those who need it? The tailored potential of pentoxifylline.
Topics: Adenosine; Animals; Humans; Immunity, Innate; Pentoxifylline; Sepsis; Vasodilator Agents | 2010 |
Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice.
Topics: Adenosine; Animals; Cecum; Chemokine CCL2; Immunoassay; Interleukin-10; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peritonitis; Punctures; Receptor, Adenosine A2A; Sepsis | 2011 |
Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacilli
Topics: Adenosine; Ampicillin; Animals; Anti-Bacterial Agents; Antigens, CD; Artemisinins; Artesunate; Bacterial Load; beta-Lactams; Cytokines; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Female; Interleukin-6; Macrophages, Peritoneal; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nod2 Signaling Adaptor Protein; Oxacillin; Penicillin-Binding Proteins; Sepsis; Staphylococcal Infections; Toll-Like Receptor 2; Tumor Necrosis Factor-alpha | 2011 |
Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.
Topics: 5'-Nucleotidase; Adenosine; Animals; Blotting, Western; Cell Separation; Chemokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Mice; Mice, Knockout; Sepsis | 2011 |
Enlarged effects of adenosine in a septic patient with multiple myeloma and atrial flutter.
Topics: Adenosine; Anti-Arrhythmia Agents; Electrocardiography; Fatal Outcome; Heart Block; Humans; Male; Middle Aged; Multiple Myeloma; Multiple Organ Failure; Sepsis; Staphylococcal Infections; Tachycardia; Tachycardia, Ventricular | 2003 |
A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Purines; Receptors, Adenosine A2; Sepsis; Survival Analysis | 2004 |
Involvement of adenosine in the antiinflammatory action of ketamine.
Topics: Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Female; Ketamine; Mice; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Sepsis | 2005 |
Regional haemodynamic responses to adenosine receptor activation vary across time following lipopolysaccharide treatment in conscious rats.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Drug Delivery Systems; Echocardiography, Doppler, Pulsed; Endotoxemia; Lipopolysaccharides; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Purinergic P1; Sepsis; Time Factors; Vasoconstriction; Vasodilation | 2008 |
Effect of sepsis on erythrocyte intracellular calcium homeostasis.
Topics: Adenosine; Adenosine Triphosphate; Adolescent; Adult; Aged; Calcium; Dantrolene; Endotoxins; Erythrocytes; Escherichia coli; Female; Homeostasis; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Verapamil | 1995 |
Evidence that adenosine contributes to maintenance of hepatosplanchnic blood flow during peritoneal sepsis in rats.
Topics: Adenosine; Animals; Liver Circulation; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sepsis; Splanchnic Circulation; Theophylline | 1997 |
Adenosine receptor antagonism affects regional resting vascular resistance during rat peritoneal sepsis.
Topics: Adenosine; Animals; Cardiac Output; Disease Models, Animal; Hemodynamics; Male; Organ Specificity; Peritonitis; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sepsis; Theophylline; Vascular Resistance | 1998 |
The unorthodox and orthodox: the therapeutic role of acadesine after traumatic injury and sepsis.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Hemodynamics; Humans; Microcirculation; Ribonucleosides; Sepsis; Shock, Hemorrhagic; Swine; Wounds and Injuries | 1999 |
Adenosine and nitric oxide regulate regional vascular resistance via interdependent and independent mechanisms during sepsis.
Topics: Adenosine; Animals; Hemodynamics; Male; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Sepsis; Vascular Resistance | 2000 |
Interdependence of adenosine and nitric oxide in hepato-splanchnic circulation during sepsis.
Topics: Adenosine; Animals; Liver Circulation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Sepsis; Splanchnic Circulation; Theophylline | 2000 |
Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation.
Topics: Adenosine; Adenosine Triphosphate; Amino Acids; Blood Bactericidal Activity; Cell Movement; Chemotaxis; Glucose; Leukocytes; Neutrophils; Parenteral Nutrition; Phagocyte Bactericidal Dysfunction; Phagocytosis; Phosphates; Sepsis | 1974 |